Related Experiment Videos
Rapid mass screening method and counseling for the 1555A-->G mitochondrial mutation
1Department of Otorhinolaryngology, Hirosaki University School of Medicine, Japan. usami@hsp.md.shinshu-u.ac.jp
Journal of Human Genetics
|September 25, 1999
Summary
A specific gene mutation (1555A-->G) can cause hearing loss, even without drug exposure. Rapid screening and counseling are recommended for the high-risk Japanese population to prevent potential side effects.
Area of Science:
- Genetics
- Pharmacogenomics
- Otolaryngology
Background:
- The 1555A-->G mitochondrial DNA mutation is linked to aminoglycoside antibiotic susceptibility.
- This mutation may independently cause non-syndromic hearing loss, irrespective of drug exposure.
- A significant population in Japan may be at risk due to this mutation.
Purpose of the Study:
- To highlight the risk of hearing loss associated with the 1555A-->G mutation.
- To emphasize the need for targeted screening and counseling in susceptible populations.
- To describe the current method for detecting the mutation.
Main Methods:
- Mutant allele specific amplification (MASA) method was employed.
- Detection of the 1555A-->G mitochondrial mutation.
Main Results:
- The 1555A-->G mutation confers susceptibility to aminoglycosides.
- The mutation can lead to hearing loss without aminoglycoside exposure.
- A substantial high-risk population exists in Japan.
Conclusions:
- Rapid mass screening for the 1555A-->G mutation is recommended for the Japanese population.
- Careful genetic counseling is advised for individuals identified with the mutation.
- Warning cards are distributed to carriers to mitigate risks.